Skip to main content
Focused investors/Seth Klarman

Seth Klarman - Baupost Group

As of Q2 2026, Seth Klarman reported 23 long-equity positions worth $5.42B in aggregate.

Copy-investor backtest

Latest quarter
+3.22%
1-year
+20.94%
3-year
+48.31%
5-year
+12.01%
3-year vs S&P 500
-25.70%
5-year vs S&P 500
-61.90%
5-year top 5
-0.29%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when Seth Klarman files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 12 of 47 rows. Rows without a quote are marked unavailable.

1LNGCHENIERE ENERGY INC11.61%Reduce -4.6%20,726,340$1.01BNo quoteNo quote
2SYFSYNCHRONY FINL10.04%Add +65.8%29,295,030$873.58M$29.82No quote
3VSATVIASAT INC10.02%-13,158,137$871.07M$66.20No quote
4CLNSCOLONY NORTHSTAR INC7.76%-47,905,461$674.99MNo quoteNo quote
5AGNALLERGAN PLC6.80%-2,432,603$591.34MNo quoteNo quote
6QRVOQORVO INC6.55%Add +25.3%9,000,000$569.88M$63.32No quote
7FOXATWENTY FIRST CENTY FOX INC6.24%-19,137,469$542.36M$28.34No quote
8ARANTERO RES CORP5.26%Add +46.0%21,170,996$457.51M$21.61No quote
9TBPHTHERAVANCE BIOPHARMA INC4.25%-9,273,991$369.48MNo quoteNo quote
10PBFPBF ENERGY INC4.02%-15,724,175$350.02M$22.26No quote
11DVMTDELL TECHNOLOGIES INC3.97%-5,652,459$345.42MNo quoteNo quote
12QCOMQUALCOMM INC3.31%-5,216,000$288.03M$55.22No quote
13FOXTWENTY FIRST CENTY FOX INC2.33%-7,278,100$202.84M$27.87No quote
14KERXKERYX BIOPHARMACEUTICALS INC2.14%-25,791,678$186.47MNo quoteNo quote
15ESRXEXPRESS SCRIPTS HLDG CO1.88%Add +108.1%2,556,891$163.23MNo quoteNo quote
16CAHCARDINAL HEALTH INC1.82%Add +97.1%2,030,000$158.18M$77.92No quote
17VRTVVERITIV CORP1.58%-3,044,385$137MNo quoteNo quote
18FWPFORWARD PHARMA A/S1.49%Add +14.2%6,364,059$129.38MNo quoteNo quote
19CARAVIS BUDGET GROUP1.25%New4,000,000$109.08MNo quoteNo quote
20ATRAATARA BIOTHERAPEUTICS INC0.86%-5,359,632$75.04MNo quoteNo quote
21IMOSCHIPMOS TECHNOLOGIES INC0.80%-3,509,858$69.39MNo quoteNo quote
22SRUNSILVER RUN ACQUISITION0.77%New6,615,552$67.02MNo quoteNo quote
23SRCSPIRIT RLTY CAP INC NEW0.77%New9,000,000$66.69MNo quoteNo quote
24PRTKPARATEK PHARMACEUTICALS INC0.66%Add +17.1%2,394,498$57.71MNo quoteNo quote
25GTYHUGTY TECHNOLOGY HOLDINGS INC0.53%-4,400,000$46.02MNo quoteNo quote
26CPAACONYERS PK ACQUISITION0.50%-3,712,500$43.73MNo quoteNo quote
27NGNOVAGOLD RES INC0.50%-9,500,000$43.32M$4.56No quote
28CDEVCENTENNIAL RESOURCE DEV INC0.42%-2,407,153$36.74MNo quoteNo quote
29CASCCASCADIAN THERAPEUTICS INC0.37%-8,721,079$32.4MNo quoteNo quote
30BATRKLIBERTY MEDIA CORP DELAWARE0.36%Reduce -34.6%1,303,482$31.24M$23.97No quote
31CACCCREDIT ACCEP CORP MICH0.29%Reduce -59.6%98,700$25.38M$257.14No quote
32SCACSABAN CAP ACQUISITION CORP0.27%-2,326,500$23.27MNo quoteNo quote
33RUNSUNRUN INC0.23%-2,848,082$20.28MNo quoteNo quote
34AIGWSAMERICAN INTL GROUP INC0.09%Reduce -71.8%354,812$7.48MNo quoteNo quote
35TMQTRILOGY METALS INC NEW0.08%-10,600,758$6.7MNo quoteNo quote
36OREXOREXIGEN THERAPEUTICS INC0.07%-2,226,839$6.46MNo quoteNo quote
37SRUNWSILVER RUN ACQUISITION0.05%New2,205,184$3.95MNo quoteNo quote
38CPAAWCONYERS PK ACQUISITION0.04%-1,237,500$3.24MNo quoteNo quote
39SCACWSABAN CAP ACQUISITION CORP0.02%-1,163,250$1.45MNo quoteNo quote
45SYTSYNGENTA AG-Sold0$0No quoteNo quote
44SRUNUSILVER RUN ACQUISITION-Sold0$0No quoteNo quote
43MCKMCKESSON CORP-Sold0$0No quoteNo quote
42LVNTALIBERTY INTERACTIVE CORP-Sold0$0No quoteNo quote
41INVAINNOVIVA INC-Sold0$0No quoteNo quote
40CORAMERISOURCEBERGEN CORP-Sold0$0No quoteNo quote

Other instruments

Bonds, warrants, or non-share principal positions reported alongside the equity portfolio.

1TBPH 3.25 11/01/23THERAVANCE BIOPHARMA INCNOTE 3.250%11/0OTHER30,000,000$40.39M
2THRXTHERAVANCE INCNOTE 2.125% 1/1OTHER16,980,000$15.46M